174 related articles for article (PubMed ID: 27398812)
1. Histological features associated with diagnostic agreement in atypical ductal hyperplasia of the breast: illustrative cases from the B-Path study.
Allison KH; Rendi MH; Peacock S; Morgan T; Elmore JG; Weaver DL
Histopathology; 2016 Dec; 69(6):1028-1046. PubMed ID: 27398812
[TBL] [Abstract][Full Text] [Related]
2. Atypical Ductal Hyperplasia Bordering on Ductal Carcinoma In Situ.
Tozbikian G; Brogi E; Vallejo CE; Giri D; Murray M; Catalano J; Olcese C; Van Zee KJ; Wen HY
Int J Surg Pathol; 2017 Apr; 25(2):100-107. PubMed ID: 27481892
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic concordance among pathologists interpreting breast biopsy specimens.
Elmore JG; Longton GM; Carney PA; Geller BM; Onega T; Tosteson AN; Nelson HD; Pepe MS; Allison KH; Schnitt SJ; O'Malley FP; Weaver DL
JAMA; 2015 Mar; 313(11):1122-32. PubMed ID: 25781441
[TBL] [Abstract][Full Text] [Related]
4. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 12 strategies for obtaining second opinions to improve interpretation of breast histopathology: simulation study.
Elmore JG; Tosteson AN; Pepe MS; Longton GM; Nelson HD; Geller B; Carney PA; Onega T; Allison KH; Jackson SL; Weaver DL
BMJ; 2016 Jun; 353():i3069. PubMed ID: 27334105
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic challenge of low-grade ductal carcinoma in situ.
Onega T; Weaver DL; Frederick PD; Allison KH; Tosteson ANA; Carney PA; Geller BM; Longton GM; Nelson HD; Oster NV; Pepe MS; Elmore JG
Eur J Cancer; 2017 Jul; 80():39-47. PubMed ID: 28535496
[TBL] [Abstract][Full Text] [Related]
7. Surgical implications and variability in the use of the flat epithelial atypia diagnosis on breast biopsy specimens.
Samples LS; Rendi MH; Frederick PD; Allison KH; Nelson HD; Morgan TR; Weaver DL; Elmore JG
Breast; 2017 Aug; 34():34-43. PubMed ID: 28475933
[TBL] [Abstract][Full Text] [Related]
8. Papillary carcinoma of the breast: diagnostic agreement and management implications.
Rakha EA; Ahmed MA; Ellis IO
Histopathology; 2016 Nov; 69(5):862-870. PubMed ID: 27270947
[TBL] [Abstract][Full Text] [Related]
9. Inter-observer agreement in the diagnosis of breast atypical ductal hyperplasia: A systematic review.
González Mariño MA
Breast Dis; 2022; 41(1):545-550. PubMed ID: 36683493
[TBL] [Abstract][Full Text] [Related]
10. Identifying and processing the gap between perceived and actual agreement in breast pathology interpretation.
Carney PA; Allison KH; Oster NV; Frederick PD; Morgan TR; Geller BM; Weaver DL; Elmore JG
Mod Pathol; 2016 Jul; 29(7):717-26. PubMed ID: 27056072
[TBL] [Abstract][Full Text] [Related]
11. The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification.
Pinder SE; Ellis IO
Breast Cancer Res; 2003; 5(5):254-7. PubMed ID: 12927035
[TBL] [Abstract][Full Text] [Related]
12. [Pathological characterization of atypical ductal hyperplasia of the breast].
Hoshi K; Tokunaga M; Mochizuki M; Ohtake T; Katagata N; Wakasa H; Suzuki T
Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():36-41. PubMed ID: 7747990
[TBL] [Abstract][Full Text] [Related]
13. Papillary lesions of the breast: impact of breast pathology subspecialization on core biopsy and excision diagnoses.
Jakate K; De Brot M; Goldberg F; Muradali D; O'Malley FP; Mulligan AM
Am J Surg Pathol; 2012 Apr; 36(4):544-51. PubMed ID: 22314186
[TBL] [Abstract][Full Text] [Related]
14. Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions.
MacGrogan G; Arnould L; de Mascarel I; Vincent-Salomon A; Penault-Llorca F; Lacroix-Triki M; Bibeau F; Baranzelli MC; Fridman V; Antoine M; Bécette V; Brouste V; Jacquemier J; Mathoulin-Pélissier S;
Histopathology; 2008 May; 52(6):689-97. PubMed ID: 18397281
[TBL] [Abstract][Full Text] [Related]
15. Pathological diagnosis of columnar cell lesions of the breast: are there issues of reproducibility?
Tan PH; Ho BC; Selvarajan S; Yap WM; Hanby A
J Clin Pathol; 2005 Jul; 58(7):705-9. PubMed ID: 15976336
[TBL] [Abstract][Full Text] [Related]
16. Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ.
Martinez AP; Cohen C; Hanley KZ; Li XB
Arch Pathol Lab Med; 2016 Jul; 140(7):686-9. PubMed ID: 27116088
[TBL] [Abstract][Full Text] [Related]
17. [Consultation in breast surgical pathology: interobserver diagnostic variability of atypical intraductal proliferative lesions].
Perez AA; Balabram D; Salles Mde A; Gobbi H
Rev Bras Ginecol Obstet; 2013 Apr; 35(4):164-70. PubMed ID: 23752581
[TBL] [Abstract][Full Text] [Related]
18. Region of interest identification and diagnostic agreement in breast pathology.
Nagarkar DB; Mercan E; Weaver DL; Brunyé TT; Carney PA; Rendi MH; Beck AH; Frederick PD; Shapiro LG; Elmore JG
Mod Pathol; 2016 Sep; 29(9):1004-11. PubMed ID: 27198567
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy.
Deshaies I; Provencher L; Jacob S; Côté G; Robert J; Desbiens C; Poirier B; Hogue JC; Vachon E; Diorio C
Breast; 2011 Feb; 20(1):50-5. PubMed ID: 20619647
[TBL] [Abstract][Full Text] [Related]
20. Atypical ductal hyperplasia: interobserver and intraobserver variability.
Jain RK; Mehta R; Dimitrov R; Larsson LG; Musto PM; Hodges KB; Ulbright TM; Hattab EM; Agaram N; Idrees MT; Badve S
Mod Pathol; 2011 Jul; 24(7):917-23. PubMed ID: 21532546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
